Table 3.

Adverse events of the third-line eradication therapy.

	RAL group†  (n = 24)	RA group ‡  (n = 24)	P value
Soft stool/diarrhea, n (%)	5 (20.8)	5 (20.8)	n.s.∗
Nausea, n (%)	0 (0)	1 (4.2)	n.s.∗
Rash, n (%)	1 (4.2)	0 (0)	n.s.∗

^†RAL group: RPZ 10 mg (b.i.d.), AMPC 750 mg (b.i.d.), and LVFX 500 mg (o.d.).

^‡RA group: RPZ 10 mg (q.i.d.) and AMPC 500 mg (q.i.d.).

^∗Chi-square test.